AzTrials
AzTrials

IntubationNCT00917566

Evaluation of Airtraq in Pediatric

A study testing Airtraq and Macintoch in people with Intubation, run by King Khaled Eye Specialist Hospital at 1 site in Saudi Arabia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study indented to evaluate the use of Optical laryngoscope in pediatric Read more about this study

Who is it for?
Ages 2 to 10 years
Conditions the study is for
Intubation
What is being tested?
Airtraq and Macintoch
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteSaudi Arabia
Study dates
Apr 2009to Nov 2009
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Healthy children undergoing general anesthesia required tracheal intubation.

Who cannot join

  • History of difficult intubation.
  • Risk of aspiration.
  • Children with cardiovascular disease.
  • Children with respiratory disease.

Trial locations and contacts

1 site in 1 country.

Saudi Arabia1 site
  • king Khaled Eye Specialist hospital

    Riyadh, Riyadh Region, 11462

Other trials in Saudi Arabia

About this study

Official title: Evaluation of Airtraq in Pediatric Population: A Prospective Randomized Study

This study indented to evaluate the use of Optical laryngoscope in pediatric

Read the detailed description

The authors are welling to study how intubation will differ if Airtraq optical laryngoscope used in pediatrics

Conditions
Intubation
Being tested
Airtraq, Macintoch
Keywords
Airtraq, Pediatric

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AirtraqDevice

    Also called Optical laryngoscope

    intubation with airtraq

  • MacintochDevice

    Also called Standard laryngoscope

    use Macintoch laryngoscope for intubation

Study groups in NCT00917566
Study groupRoleWhat they receive
Airtraq groupActive comparatorUse Airtraq for intubation
Receives: Device: Airtraq
Macintoch gorupActive comparatorUse Macintoch laryngoscope for intubation
Receives: Device: Macintoch

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Duration of intubation

    Measured: two minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jun 2009 (estimated)
  2. Study startApr 2009
  3. Primary completionNov 2009
  4. Study completionNov 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00917566
Sponsor's protocol ID
RP 0909
Status last verified
Nov 2009
First submitted
9 Jun 2009
Last updated
19 Nov 2009
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Airtraq and Macintoch in people with Intubation, run by King Khaled Eye Specialist Hospital at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Nov 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Duration of intubation (time frame: two minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Nov 2009.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in